Catalyst Wire Dossier Catalyst Wire Dossier

rhPTH(1-84)

recombinant human parathyroid hormone 1-84 · Shire
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for rhPTH(1-84), covering 2015-03-06 to 2023-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy Adults [Phase 1]

See pricing